A diagnostic method for determining prognosis of a myocardial infarcted patient, wherein the amounts of FXIII protein are determined on the day of myocardial infarction (t0) and at least on the following three days (t1 to t3), wherein a lowering of FXIII amount on any one of t0 to t3 below a threshold value is indicative of an increased risk of poor prognosis (Left Ventricular Remodeling (LVR); severe heart failure; heart rupture; death).
KIT FOR DETERMINING FXIII LEVELS AS A PROGNOSTIC BIOMARKER IN ACUTE MYOCARDIAL INFARCTION
GEMMATI, Donato
2016
Abstract
A diagnostic method for determining prognosis of a myocardial infarcted patient, wherein the amounts of FXIII protein are determined on the day of myocardial infarction (t0) and at least on the following three days (t1 to t3), wherein a lowering of FXIII amount on any one of t0 to t3 below a threshold value is indicative of an increased risk of poor prognosis (Left Ventricular Remodeling (LVR); severe heart failure; heart rupture; death).File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in SFERA sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
